IOPIDINE
Google image searchProduct monograph
Active ingredient
apraclonidine (apraclonidine hydrochloride), 0.5 %/W/V
DIN: 02076306
Dosage form(s): SOLUTION
Route(s) of administration: OPHTHALMIC
Schedule: Prescription
Company: ESSENTIAL PHARMA SWITZERLAND GMBH
Date: 19-MAY-2023
ATC:
- S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
- S01E — ANTIGLAUCOMA PREPARATIONS AND MIOTICS (ATC, ATC/DDD)
- S01EA — Sympathomimetics in glaucoma therapy (ATC, ATC/DDD)
- S01EA03 — APRACLONIDINE (ATC/DDD)
Reference brand drug: Iopidine
Pharmaceutical standard: USP
